Keep Updated May 2015

Treatment for ADPKD approved in Europe

From the Business Wire Press Release: TOKYO—(BUSINESS WIRE)—Otsuka Pharmaceutical Co., Ltd. announced today that the European Commission has granted marketing authorisation for JINARC® (tolvaptan) for the treatment of ADPKD in adults who have chronic kidney disease (CKD) stage one to […]

PKD Foundation |